Top-News

Juniper Pharmaceuticals News

Keine aktuellen Kursdaten verfügbar
WKN: A14RRF
ISIN: US48203L1070
US-Symbol: JNP
Typ: Aktie

Juniper Pharmaceuticals News

09.08.18 - PR Newswire
Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results
Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results Signs Agreement to be Acquired by Catalent, Inc. CRINONE® Revenues Increased 12% ...
10.07.18 - PR Newswire
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation of Juniper Pharmaceuticals, Inc. - JNP
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation of Juniper Pharmaceuticals, Inc. - JNP PR Newswire
05.07.18 - PR Newswire
WeissLaw LLP Investigates Juniper Pharmaceuticals, Inc.
WeissLaw LLP Investigates Juniper Pharmaceuticals, Inc. PR Newswire
03.07.18 - PR Newswire
Juniper (JNP) Alert: Johnson Fistel Investigates Proposed Sale of Juniper Pharmaceuticals, Inc.; Are Shareholders Getting a Fair Deal?
Juniper (JNP) Alert: Johnson Fistel Investigates Proposed Sale of Juniper Pharmaceuticals, Inc.; Are Shareholders Getting a Fair Deal? PR Newswire
03.07.18 - PR Newswire
Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash
Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash PR Newswire
10.05.18 - PR Newswire
Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results
Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results Core Businesses Driving Strong Financial Performance CRINONE® Revenues Increased ...
01.05.18 - PR Newswire
Juniper Pharmaceuticals to Report First Quarter 2018 Results on May 10, 2018
Juniper Pharmaceuticals to Report First Quarter 2018 Results on May 10, 2018 Conference Call Scheduled for 8:30 a.m. EST PR Newswire
25.04.18 - PR Newswire
Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience
Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience -Company Eligible to Receive Up to $43.75 Million in Milestones for Each IVR Candidate, ...
08.03.18 - PR Newswire
Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results
Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results Full Year CRINONE® Revenues Increased 20% and Juniper Pharma Services (JPS) Revenues ...
02.03.18 - PR Newswire
Juniper Pharmaceuticals to Report Fourth Quarter and Year-End 2017 Results on March 8, 2018
Juniper Pharmaceuticals to Report Fourth Quarter and Year-End 2017 Results on March 8, 2018 Conference Call Scheduled for 8:30 a.m. EST PR Newswire
31.01.18 - PR Newswire
Juniper Pharmaceuticals to Explore Strategic Alternatives
Juniper Pharmaceuticals to Explore Strategic Alternatives PR Newswire
08.01.18 - PR Newswire
Juniper Pharmaceuticals Announces 4.5-Year Extension through 2024 of CRINONE® Supply Agreement with Merck KGaA, Darmstadt, Germany
Juniper Pharmaceuticals Announces 4.5-Year Extension through 2024 of CRINONE® Supply Agreement with Merck KGaA, Darmstadt, Germany PR Newswire
02.01.18 - PR Newswire
Juniper Pharmaceuticals Outlines Strategic Priorities for 2018 and Reports Recent Portfolio Progress
Juniper Pharmaceuticals Outlines Strategic Priorities for 2018 and Reports Recent Portfolio Progress Continued Double-​digit Revenue Growth in Core Business Expected in 2018 ...
29.12.17 - PR Newswire
Juniper Pharma Services' co-founder awarded CBE in the Queen's New Year's Honours List
Juniper Pharma Services' co-​founder awarded CBE in the Queen's New Year's Honours List PR Newswire
02.11.17 - PR Newswire
Juniper Pharmaceuticals Reports Third Quarter 2017 Financial and Operating Results
Juniper Pharmaceuticals Reports Third Quarter 2017 Financial and Operating Results CRINONE® Revenues Increased 19% and Juniper Pharma Services Revenues Increased ...
26.10.17 - PR Newswire
Juniper Pharmaceuticals to Report Third Quarter 2017 Results on November 2, 2017
Juniper Pharmaceuticals to Report Third Quarter 2017 Results on November 2, 2017 Conference Call Scheduled for 4:30 p.m. EDT PR Newswire
18.09.17 - PR Newswire
Juniper Pharmaceuticals Announces Strategic Reprioritization
Juniper Pharmaceuticals Announces Strategic Reprioritization - Changes Designed to Drive Continued Growth in Core Businesses of Crinone® and Juniper Pharma Services, ...
11.09.17 - PR Newswire
Juniper Pharmaceuticals Appoints Jennifer Good to Board of Directors
Juniper Pharmaceuticals Appoints Jennifer Good to Board of Directors - Board of Directors accepts resignation of Frank Armstrong - PR Newswire
03.08.17 - PR Newswire
Juniper Pharmaceuticals Reports Second Quarter 2017 Financial and Operating Results
Juniper Pharmaceuticals Reports Second Quarter 2017 Financial and Operating Results CRINONE® Revenues Increased 30% and Juniper Pharma Services Revenues increase ...
27.07.17 - PR Newswire
Juniper Pharmaceuticals to Report Second Quarter 2017 Results on August 3, 2017
Juniper Pharmaceuticals to Report Second Quarter 2017 Results on August 3, 2017 Conference Call Scheduled for 4:30 p.m. EST PR Newswire

Newssuche

Videos

newspaper
08:50 Uhr
Technical Trading: AUD/USD mit Mega Chance
AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »